MANAGEMENT OF PATIENTS WITH PULMONARY ARTERIAL HYPERTENSION IN THE PANDEMIC OF A NEW CORONAVIRUS INFECTION
The pandemic of a new coronavirus infection – COVID-19 («Coronavirus disease 2019») has changed the routine management of patients with pulmonary arterial hypertension (PAH). Like patients with other chronic cardiovascular diseases, PAH patients are not at higher risk of a new coronavirus infection....
Saved in:
Main Authors: | T. V. Martynyuk, A. M. Aleevskaya, O. V. Rodnenkov, A. V. Zorin, A. M. Kasparova, S. N. Nakonechnikov, I. E. Chazova |
---|---|
Format: | Article |
Language: | Russian |
Published: |
InterMedservice
2020-06-01
|
Series: | Евразийский Кардиологический Журнал |
Subjects: | |
Online Access: | https://www.heartj.asia/jour/article/view/6208 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
FEATURES OF PULMONARY ARTERIAL HYPERTENSION IN THE RUSSIAN REGISTER
by: O. A. Arkhipova, et al.
Published: (2014-12-01) -
Patient and disease characteristics of pulmonary arterial hypertension patients for prostacyclin receptor agonist selexipag treatment initiation
by: E. A. Rezukhina, et al.
Published: (2023-03-01) -
The clinical profile of pulmonary arterial hypertension in newly diagnosed patients with connective tissue disease from the point of view of the cardiologist
by: E. A. Rezukhina, et al.
Published: (2023-05-01) -
THE ROLE OF RIOCIGUAT IN THE TREATMENT OF PULMONARY ARTERIAL HYPERTENSION ASSOCIATED WITH CONNECTIVE TISSUE DISEASE
by: O. Ya. Vasiltseva, et al.
Published: (2019-12-01) -
PULMONARY ARTERIAL HYPERTENSION DIAGNOSTICS SPECIFICS IN SYSTEMIC SCLERODERMIA
by: M. A. Simakova, et al.
Published: (2016-11-01)